Literature DB >> 2813401

Specific binding of angiogenin to calf pulmonary artery endothelial cells.

J Badet1, F Soncin, J D Guitton, O Lamare, T Cartwright, D Barritault.   

Abstract

Specific binding of angiogenin (ANG) to calf pulmonary artery endothelial cells was demonstrated. Cellular binding at 4 degrees C of 125I-labeled human recombinant ANG was time and concentration dependent, reversible, and saturable in the presence of increasing amounts of the unlabeled molecules. The interaction was shown to be specific since a large excess of unlabeled ANG reduced labeled ANG binding by 80%, whereas similar doses of RNase A, a structurally related protein, had no effect. Scatchard analyses of binding data revealed two apparent components. High-affinity sites with an apparent dissociation constant of 5 x 10(-9) M were shown to represent cell-specific interactions. The second component, comprising low-affinity/high-capacity sites with an apparent dissociation constant of 0.2 x 10(-6) M, was essentially associated with pericellular components. High-affinity ANG binding sites varied with cell density and were found on other endothelial cells from bovine aorta, cornea, and adrenal cortex capillary but not on Chinese hamster lung fibroblasts. Divalent copper, a modulator of angiogenesis, was found to induce a severalfold increase in specific cell-bound radioactivity. Placental ribonuclease inhibitor, a tight-binding inhibitor of both ribonucleolytic and angiogenic activities of ANG, abolished 125I-labeled human recombinant ANG binding only in the absence of copper.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813401      PMCID: PMC298295          DOI: 10.1073/pnas.86.21.8427

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  Unmasking of nerve growth factor membrane-specific binding sites in synchronized murine C 1300 neuroblastoma cells.

Authors:  R Revoltella; L Bertolini; M Pediconi
Journal:  Exp Cell Res       Date:  1974-03-30       Impact factor: 3.905

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Density-dependent regulation of growth of BSC-1 cells in cell culture: control of growth by serum factors.

Authors:  R W Holley; R Armour; J H Baldwin; K D Brown; Y C Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

6.  Biochemical comparative studies between eye- and brain-derived growth factors.

Authors:  J Courty; C Loret; B Chevallier; M Moenner; D Barritault
Journal:  Biochimie       Date:  1987-05       Impact factor: 4.079

7.  Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.

Authors:  F S Lee; R Shapiro; B L Vallee
Journal:  Biochemistry       Date:  1989-01-10       Impact factor: 3.162

8.  Amino acid sequence of human tumor derived angiogenin.

Authors:  D J Strydom; J W Fett; R R Lobb; E M Alderman; J L Bethune; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

9.  Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor.

Authors:  K Kurachi; E W Davie; D J Strydom; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

10.  Ribonuclease inhibitor from human placenta. Purification and properties.

Authors:  P Blackburn; G Wilson; S Moore
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

View more
  32 in total

1.  Dual site model for the organogenic activity of angiogenin.

Authors:  T W Hallahan; R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 2.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

3.  Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions.

Authors:  M Moenner; E Hatzi; J Badet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

Review 4.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

5.  Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.

Authors:  Virginia Urquidi; Steve Goodison; Jeongsoon Kim; Myron Chang; Yunfeng Dai; Charles J Rosser
Journal:  Urology       Date:  2012-03-03       Impact factor: 2.649

6.  Angiogenin in sera as an independent prognostic factor in gastric cancer.

Authors:  Shouji Shimoyama; Michio Kaminishi
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-08       Impact factor: 4.553

7.  A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice.

Authors:  I J Polakowski; M K Lewis; V R Muthukkaruppan; B Erdman; L Kubai; R Auerbach
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Angiogenin supports endothelial and fibroblast cell adhesion.

Authors:  F Soncin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 9.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

10.  Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.

Authors:  G Hu; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.